Literature DB >> 10835030

Recurrent bacteremic peritonitis caused by Enterococcus cecorum in a patient with liver cirrhosis.

P R Hsueh1, L J Teng, Y C Chen, P C Yang, S W Ho, K T Luh.   

Abstract

Enterococcus cecorum (formerly Streptococcus cecorum), originally isolated from poultry intestines, has rarely been encountered in human diseases. A 60-year-old man with liver cirrhosis and hepatocellular carcinoma developed peritonitis on the seventh day of his hospitalization. Cultures of one blood sample and one ascites fluid sample obtained on that day both grew E. cecorum. The patient received intravenous cefoxitin therapy and initially responded well. Unfortunately, another episode of peritonitis associated with septic shock developed 24 days after the start of treatment, and culture of one blood specimen yielded the same organism. The isolates were identified by the conventional biochemical tests, the API Rapid ID 32 Strep system, and the API ZYM system (both systems from bioMerieux, Marcy L'Etoile, France) and were further confirmed by cellular fatty acid chromatography and 16S rRNA gene partial sequencing. The identical biotype, antibiotype, and random amplified polymorphic DNA pattern of the three isolates documented the long-term persistence of this organism in the patient. To the best of our knowledge, this is the first clinical description of recurrent bacteremic peritonitis caused by E. cecorum.

Entities:  

Mesh:

Year:  2000        PMID: 10835030      PMCID: PMC86842          DOI: 10.1128/JCM.38.6.2450-2452.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Use of rapid, nonradioactive DNA probes in culture confirmation tests to detect Streptococcus agalactiae, Haemophilus influenzae, and Enterococcus spp. from pediatric patients with significant infections.

Authors:  J A Daly; N L Clifton; K C Seskin; W M Gooch
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

2.  Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: persistence of multiple species and multiple clones.

Authors:  P R Hsueh; L J Teng; H J Pan; Y C Chen; L H Wang; S C Chang; S W Ho; K T Luh
Journal:  Infect Control Hosp Epidemiol       Date:  1999-12       Impact factor: 3.254

3.  Evaluation of arbitrarily primed PCR analysis and pulsed-field gel electrophoresis of large genomic DNA fragments for identification of enterococci important in human medicine.

Authors:  P Descheemaeker; C Lammens; B Pot; P Vandamme; H Goossens
Journal:  Int J Syst Bacteriol       Date:  1997-04

4.  Enterococcus cecorum septicemia in a malnourished adult patient.

Authors:  G Greub; L A Devriese; B Pot; J Dominguez; J Bille
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-08       Impact factor: 5.103

5.  Identification and composition of the streptococcal and enterococcal flora of tonsils, intestines and faeces of pigs.

Authors:  L A Devriese; J Hommez; B Pot; F Haesebrouck
Journal:  J Appl Bacteriol       Date:  1994-07

6.  Phenotypic characterization, cellular fatty acid composition, and DNA relatedness of aerococci and comparison to related genera.

Authors:  G S Bosley; P L Wallace; C W Moss; A G Steigerwalt; D J Brenner; J M Swenson; G A Hebert; R R Facklam
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

7.  PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid.

Authors:  K Greisen; M Loeffelholz; A Purohit; D Leong
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

  7 in total
  11 in total

1.  Continuous ambulatory peritoneal dialysis peritonitis due to Enterococcus cecorum.

Authors:  T De Baere; G Claeys; G Verschraegen; L A Devriese; M Baele; B Van Vlem; R Vanholder; C Dequidt; M Vaneechoutte
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

2.  Identification of clinically relevant enterococcus species by direct sequencing of groES and spacer region.

Authors:  Jui-Chang Tsai; Po-Ren Hsueh; Hsiao-Mann Lin; Hui-Jen Chang; Shen-Wu Ho; Lee-Jene Teng
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

3.  Mycotic Aneurysm Caused by Streptococcus constellatus subsp. constellatus.

Authors:  Wen-Chu Chiang; Jui-Chang Tsai; Shey-Ying Chen; Chiung-Yuan Hsu; Chen-Tu Wu; Lee-Jene Teng; Po-Ren Hsueh
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

4.  Enterococcus cecorum empyema thoracis successfully treated with cefotaxime.

Authors:  Patrick C Y Woo; Dorothy M W Tam; Susanna K P Lau; Ami M Y Fung; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

5.  Infectious complications of cirrhosis.

Authors:  O S Brann
Journal:  Curr Gastroenterol Rep       Date:  2001-08

6.  Nosocomial infection due to Enterococcus cecorum identified by MALDI-TOF MS and Vitek 2 from a blood culture of a septic patient.

Authors:  Philipp Warnke; Thomas Köller; Paul Stoll; Andreas Podbielski
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-06-18

7.  Enterococcus cecorum human infection, France.

Authors:  E Delaunay; C Abat; J-M Rolain
Journal:  New Microbes New Infect       Date:  2015-06-15

8.  Comparative genomic analysis identifies divergent genomic features of pathogenic Enterococcus cecorum including a type IC CRISPR-Cas system, a capsule locus, an epa-like locus, and putative host tissue binding proteins.

Authors:  Luke B Borst; M Mitsu Suyemoto; Elizabeth H Scholl; Fredrick J Fuller; H John Barnes
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

9.  Comparison of pathogenic and non-pathogenic Enterococcus cecorum strains from different animal species.

Authors:  Arne Jung; Martin Metzner; Martin Ryll
Journal:  BMC Microbiol       Date:  2017-02-13       Impact factor: 3.605

10.  Little cigars and cigarillos harbor diverse bacterial communities that differ between the tobacco and the wrapper.

Authors:  Suhana Chattopadhyay; Eoghan M Smyth; Prachi Kulkarni; Kelsey R Babik; Molly Reid; Lauren E Hittle; Pamela I Clark; Emmanuel F Mongodin; Amy R Sapkota
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.